Is Aditxt Inc. (ADTX) undervalued? · rev $134.0K
Aditxt Inc. (ADTX) is a biotechnology company listed on NASDAQ.
This page asks whether Aditxt Inc. (ADTX) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Latest reported ADTX revenue for 2024-12-31 was $134.0K. Net income was -$35.0M. Revenue was down 79.2% from 2023-12-31 to 2024-12-31. ADTX currently screens at market cap $3.6K.
ADTX currently screens at market cap $3.6K. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new ADTX 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare ADTX to the stock page model before you treat a low multiple as a gift.
Not investment advice.